Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children.

Tercyak KP, Mays D, DeMarco TA, Peshkin BN, Valdimarsdottir HB, Schneider KA, Garber JE, Patenaude AF.

Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1260-6. doi: 10.1158/1055-9965.EPI-13-0198.


Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.

Tercyak KP, Peshkin BN, Demarco TA, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Schwartz MD.

Genet Test. 2007 Fall;11(3):249-55.


Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children.

Sharff ME, DeMarco TA, Mays D, Peshkin BN, Valdimarsdottir HB, Garber JE, Schneider KA, Patenaude AF, Tercyak KP.

Genet Test Mol Biomarkers. 2012 May;16(5):376-82. doi: 10.1089/gtmb.2011.0154. Epub 2011 Nov 15.


Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.

Mays D, DeMarco TA, Luta G, Peshkin BN, Patenaude AF, Schneider KA, Garber JE, Tercyak KP.

Health Psychol. 2014 Aug;33(8):765-73. doi: 10.1037/a0033418. Epub 2013 Jun 24.


Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children.

DeMarco TA, Peshkin BN, Valdimarsdottir HB, Patenaude AF, Schneider KA, Tercyak KP.

J Genet Couns. 2008 Jun;17(3):283-7. doi: 10.1007/s10897-007-9147-7. Epub 2008 Feb 21.


An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers.

Segal J, Esplen MJ, Toner B, Baedorf S, Narod S, Butler K.

Am J Med Genet A. 2004 Mar 15;125A(3):267-72.


Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice.

Farkas Patenaude A, DeMarco TA, Peshkin BN, Valdimarsdottir H, Garber JE, Schneider KA, Hewitt L, Hamilton J, Tercyak KP.

J Genet Couns. 2013 Jun;22(3):303-14. doi: 10.1007/s10897-012-9549-z. Epub 2012 Oct 24.


On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children.

Peshkin BN, Demarco TA, Tercyak KP.

Fam Cancer. 2010 Mar;9(1):89-97. doi: 10.1007/s10689-009-9267-3. Epub 2009 Jul 17.


Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.

Finlay E, Stopfer JE, Burlingame E, Evans KG, Nathanson KL, Weber BL, Armstrong K, Rebbeck TR, Domchek SM.

Genet Test. 2008 Mar;12(1):81-91. doi: 10.1089/gte.2007.0037.


Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.

Patrick-Miller L, Egleston BL, Daly M, Stevens E, Fetzer D, Forman A, Bealin L, Rybak C, Peterson C, Corbman M, Bradbury AR.

Patient Educ Couns. 2013 Dec;93(3):413-9. doi: 10.1016/j.pec.2013.08.009. Epub 2013 Aug 19.


How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.

Bradbury AR, Dignam JJ, Ibe CN, Auh SL, Hlubocky FJ, Cummings SA, White M, Olopade OI, Daugherty CK.

J Clin Oncol. 2007 Aug 20;25(24):3705-11.


Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?

Maheu C, Bouhnik AD, Nogues C, Mouret-Fourme E, Stoppa-Lyonnet D, Lasset C, Berthet P, Fricker JP, Caron O, Luporsi E, Gladieff L, Julian-Reynier C.

Psychooncology. 2014 Apr;23(4):420-7. doi: 10.1002/pon.3435. Epub 2013 Oct 11.


Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.

Flores KG, Steffen LE, McLouth CJ, Vicuña BE, Gammon A, Kohlmann W, Vigil L, Dayao ZR, Royce ME, Kinney AY.

J Genet Couns. 2017 Jun;26(3):480-490. doi: 10.1007/s10897-016-0001-7. Epub 2016 Aug 6.


Parent-child factors and their effect on communicating BRCA1/2 test results to children.

Tercyak KP, Peshkin BN, DeMarco TA, Brogan BM, Lerman C.

Patient Educ Couns. 2002 Jun;47(2):145-53.


Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes.

Sie AS, Prins JB, Spruijt L, Kets CM, Hoogerbrugge N.

Fam Cancer. 2013 Dec;12(4):675-82. doi: 10.1007/s10689-013-9644-9.


When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response.

Bradbury AR, Patrick-Miller L, Egleston BL, Olopade OI, Daly MB, Moore CW, Sands CB, Schmidheiser H, Kondamudi PK, Feigon M, Ibe CN, Daugherty CK.

Cancer. 2012 Jul 1;118(13):3417-25. doi: 10.1002/cncr.26471. Epub 2012 Jan 9.


Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.

Graves KD, Wenzel L, Schwartz MD, Luta G, Wileyto P, Narod S, Peshkin BN, Marcus A, Cella D, Emsbo SP, Barnes D, Halbert CH.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):648-54. doi: 10.1158/1055-9965.EPI-09-0548. Epub 2010 Mar 3.


Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.

Bradbury AR, Patrick-Miller L, Fetzer D, Egleston B, Cummings SA, Forman A, Bealin L, Peterson C, Corbman M, O'Connell J, Daly MB.

Clin Genet. 2011 Feb;79(2):125-31. doi: 10.1111/j.1399-0004.2010.01540.x. Epub 2010 Oct 12.


Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.

Schwartz MD, Valdimarsdottir HB, DeMarco TA, Peshkin BN, Lawrence W, Rispoli J, Brown K, Isaacs C, O'Neill S, Shelby R, Grumet SC, McGovern MM, Garnett S, Bremer H, Leaman S, O'Mara K, Kelleher S, Komaridis K.

Health Psychol. 2009 Jan;28(1):11-9. doi: 10.1037/a0013147.

Supplemental Content

Support Center